These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3117973

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Uptake of 3-[125I]iodo-alpha-methyl-L-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs.
    Shikano N, Ogura M, Okudaira H, Nakajima S, Kotani T, Kobayashi M, Nakazawa S, Baba T, Yamaguchi N, Kubota N, Iwamura Y, Kawai K.
    Nucl Med Biol; 2010 Feb; 37(2):197-204. PubMed ID: 20152719
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Synthesis of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) with thermostabilized low-specific L-threonine aldolase from Streptomyces coelicolor A3(2).
    Balk SH, Yoshioka H, Yukawa H, Harayama S.
    J Microbiol Biotechnol; 2007 May; 17(5):721-7. PubMed ID: 18051291
    [Abstract] [Full Text] [Related]

  • 47. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
    Azuma T, Suzuki T, Mizuno R, Tsujino S, Kishimoto S, Mizuta E, Ichikawa K.
    Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
    [Abstract] [Full Text] [Related]

  • 48. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W, Naoi M, Narabayashi H.
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [Abstract] [Full Text] [Related]

  • 49. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S, Oyabe A, Tanno M, Suzuki-Kusaba M.
    Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
    [Abstract] [Full Text] [Related]

  • 50. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
    Suzuki T, Higa S, Tsuge I, Sakoda S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A.
    Eur J Clin Pharmacol; 1980 Jun; 17(6):429-35. PubMed ID: 6772451
    [Abstract] [Full Text] [Related]

  • 51. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
    Birkmayer W, Birkmayer G, Lechner H, Riederer P.
    J Neural Transm; 1983 Jun; 58(3-4):305-13. PubMed ID: 6420517
    [Abstract] [Full Text] [Related]

  • 52. The role of L-threo DOPS in the control of Na-K ATPase activity of the marginal cells in the stria vascularis of reserpinized guinea pigs.
    Kanoh N, Nomura J.
    Acta Otolaryngol Suppl; 1995 Jun; 520 Pt 2():381-3. PubMed ID: 8749167
    [Abstract] [Full Text] [Related]

  • 53. The effect of L-threo-DOPS on synaptic transmission to soleus motoneuron in normal subjects and patients with Parkinson's disease.
    Nakajima Y, Kagamihara Y, Nagaoka M, Tanaka R.
    Neurosci Res; 1987 Oct; 5(1):16-27. PubMed ID: 2829065
    [Abstract] [Full Text] [Related]

  • 54. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J, Takahashi R.
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [Abstract] [Full Text] [Related]

  • 55. [D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia].
    Kondo T.
    Rinsho Shinkeigaku; 1984 Mar; 24(3):280-8. PubMed ID: 6432393
    [No Abstract] [Full Text] [Related]

  • 56. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS, Holmes C, Kaufmann H, Freeman R.
    Clin Auton Res; 2004 Dec; 14(6):363-8. PubMed ID: 15666063
    [Abstract] [Full Text] [Related]

  • 57. Uptake of [3H]L-serine in rat brain synaptosomal fractions.
    Takarada T, Balcar VJ, Baba K, Takamoto A, Acosta GB, Takano K, Yoneda Y.
    Brain Res; 2003 Sep 05; 983(1-2):36-47. PubMed ID: 12914964
    [Abstract] [Full Text] [Related]

  • 58. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P.
    Gen Pharmacol; 1993 Jan 05; 24(1):75-81. PubMed ID: 8482506
    [Abstract] [Full Text] [Related]

  • 59. Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.
    Langlais PJ, Mair RG, Whalen PJ, McCourt W, McEntee WJ.
    Psychopharmacology (Berl); 1988 Jan 05; 95(2):250-4. PubMed ID: 3137605
    [Abstract] [Full Text] [Related]

  • 60. [The effective of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in hypersomnia and subcortical dementia caused by bilateral medial thalamic and midbrain infarcts].
    Komiya T, Narabayashi H, Kondo T.
    Rinsho Shinkeigaku; 1988 Mar 05; 28(3):268-71. PubMed ID: 3135970
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.